Key player · Company profile
Roche Diagnostics
Named as a key player in 264 of our reports, across 33 regions and countries.
Named as a key player in 264 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 8
Brazil 8
Canada 8
China 8
Ecuador 8
Egypt 8
France 8
Germany 8
Hong Kong 8
India 8
Italy 8
Japan 8
Kenya 8
Malaysia 8
Mexico 8
New Zealand 8
Philippines 8
Russia 8
Saudi Arabia 8
Singapore 8
South Africa 8
Spain 8
Thailand 8
UAE 8
UK 8
US 8| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Healthcare In Vitro Diagnostic | Healthcare Services | $83.5 Bn | 3.8% |
| Point of Care Diagnostics | Digital Health | $45.4 Bn | 7.4% |
| Point Of Care (PoC) Molecular Diagnostic | Healthcare Services | $18.7 Bn | 9.3% |
| Nursing Education | Healthcare Services | $10.3 Bn | 8.1% |
| Pathology Imaging Systems | Digital Health | $1.6 Bn | 11.9% |
| Digital Pathology Systems | Digital Health | $1.2 Bn | 13.7% |
| Bone Cancer Diagnostic | Healthcare Services | $1.1 Bn | 7.4% |
| Brain Imaging, Biomarkers and NeuroInformatics | Digital Health | $680 Mn | 4.7% |
Named as key players in the same markets as Roche Diagnostics (number of shared markets).
Siemens Healthineers6 shared markets
Abbott Laboratories5 shared markets
Becton, Dickinson and Company (BD)4 shared markets
bioMérieux SA4 shared markets
Thermo Fisher Scientific Inc.4 shared markets
Danaher Corporation3 shared markets
GE Healthcare3 shared markets
Philips Healthcare3 shared markets